One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Chondroitin Sulfate other active pharmaceutical ingredients
Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients Product Name:Chondroitin Sulfate other active pharmaceutical ingredients CAS No.:9007-28-7 Standard:USP, EP Price(USD):0.00 Company:LAIYANG CHONDROPHARM BIOCHEMICAL CO LTD
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Monthly Production Capacity: 10 TONS
Packaging Information: packaging : Length x Width x Height shipping_port : Qingdao or other ports
Sample Provided: yes
Payment Terms: L/C, T/T, D/P
Chondroitin Sulfate is a kind of acid mucopolysaccharide extracted from animal cartilages. It is composed of chondroitin sulfate A, C and others, which are widely present in cartilages of fish, mammal and poultry. In cartilages chondroitin sulfate bound with protein as glycoprotein and collagen protein.Chondroitin Sulfate is a white powder, odourless, tasteless, hygroscopicity, freely soluble in water and insoluble in organic solvent such as ethanol, acetone, aether and so on. Chondroitin sulfate aqueous solution is instable under high temperature or acid, deacetylation degrade into monosaccharide or low molecular weight polysaccharide.Chondroitin Sulfate works effectively in reducing blood lipid and can also be used as additive in foodstuffs and health products.Our company can supply you with self-produced shark, bovine, porcine, chicken and terrestrial CS, with high quality and competitive price. The segregate products can be 80%, 85%, 90% and 95%, or over 98% in CPC purity,
Eight years of qualification
Audited Supplier
Pharma Sources Insight January 2025
